The goal is to find the dose that provides effective appetite reduction and metabolic benefit with manageable or absent side effects
In 2007, for example, a study found that participants with nonalcoholic fatty liver disease saw a "significant reduction" in disease indicators after treatment with silymarin in a phospholipid complex (sort of like the type used in our overall winner, Life Extension)
Peer review Peer review information Nature Communications thanks Chao Xu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
A liposome is an extremely small (1/2 the width of a human hair), multi-layered bubble (called a vesicle)
Losing access to a life-changing drug Most employer insurance plans dont cover popular GLP-1 medications like Wegovy and Zepbound or any other medications for weight loss, for that matter
Its best to consult with a healthcare provider for personalized recommendations